@article{MatlachSloboddaGrehnetal.2012, author = {Matlach, Juliane and Slobodda, Joerg and Grehn, Franz and Klink, Thomas}, title = {Pars plana vitrectomy for malignant glaucoma in non-glaucomatous and in filtered glaucomatous eyes}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-76375}, year = {2012}, abstract = {Purpose: To assess the outcomes of pars plana vitrectomy for the treatment of malignant glaucoma in patients with and without previous filtration surgery. Patients and methods: Data of 15 patients developing malignant glaucoma after trabeculectomy (60\%) or following ophthalmic interventions other than filtration surgery (40\%) were recorded retrospectively. Pars plana vitrectomy was performed in case of failed medical or laser treatment recreating the normal pathway of aqueous humor. The main outcome measures were the postoperative intraocular pressure (IOP), the frequency of complications, and success rate based on the following criteria: IOP reduction by \$20\% and to \#21 mmHg (definition one) or an IOP , 18 mmHg (definition two) with (qualified success) and without (complete success) glaucoma medication. Results: Vitrectomy reduced IOP from baseline in eyes with and without previous trabeculectomy during a median follow-up of 16.4 months (range 7 days to 58 months); although the majority of patients required glaucoma medication to reach desired IOP. The complete success rates were 11\% (both definitions) for patients with filtering blebs and none of the patients without previous trabeculectomy had complete success at the 12-month visit. Complications were few and included transient shallowing of the anterior chamber, choroidal detachment, corneal decompensation, filtering bleb failure, and need for further IOP-lowering procedures. Conclusion: Pars plana vitrectomy is equally effective for malignant glaucoma caused by trabeculectomy or interventions other than filtration surgery, although IOP-lowering medication is necessary in nearly all cases to maintain target IOP.}, subject = {Medizin}, language = {en} } @article{MatlachHoffmannFreibergetal.2012, author = {Matlach, Juliane and Hoffmann, Niels and Freiberg, Florentina J. and Grehn, Franz and Klink, Thomas}, title = {Comparative study of trabeculectomy using single sutures versus releasable sutures}, series = {Clinical ophthalmology}, volume = {6}, journal = {Clinical ophthalmology}, doi = {http://dx.doi.org/10.2147/OPTH.S32503}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-123715}, pages = {1019-1027}, year = {2012}, abstract = {BACKGROUND: The purpose of this study was to compare the outcomes of trabeculectomy using single sutures or releasable sutures. METHODS: This retrospective study analyzed the medical records of 61 patients who had undergone trabeculectomy using single sutures (n = 33, 54.1\%) or releasable sutures (n = 28, 45.9\%). The scleral flap was secured with a mean 3.9 (range 3-5) single sutures in 33 patients and with three releasable sutures in 28 patients. Primary outcomes were the success rate, based on intraocular pressure and medication usage, and the frequency of complications and post-surgical interventions. The criteria used to determine complete success were, first, intraocular pressure < 18 mmHg and, second, <=21 mmHg and >=20\% intraocular pressure reduction without glaucoma medication. RESULTS: All patients had an intraocular pressure <= 21 mmHg; 87.5\% in the single suture group and 92.6\% in the releasable suture group had an intraocular pressure < 18 mmHg at 24 months. There was a highly significant reduction in intraocular pressure to baseline values in both groups at the last visit. Applying the first criterion, complete success was achieved in 57.6\% of patients with single sutures and 71.4\% with releasable sutures, and based on the second criterion, 66.7\% and 71.4\%, respectively. No significant difference was found between the groups with regard to intraocular pressure, or success or complication rates. CONCLUSION: The results of trabeculectomy using single sutures or releasable sutures are equivalent. Therefore, the choice of suture technique should be based on individual patient requirements and surgeon experience.}, language = {en} } @article{MatlachFreibergLeippietal.2013, author = {Matlach, Juliane and Freiberg, Florentina Joyce and Leippi, Swetlana and Grehn, Franz and Klink, Thomas}, title = {Comparison of phacotrabeculectomy versus phacocanaloplasty in the treatment of patients with concomitant cataract and glaucoma}, series = {BMC Ophthalmology}, journal = {BMC Ophthalmology}, doi = {10.1186/1471-2415-13-1}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-95948}, year = {2013}, abstract = {Background Cataract and glaucoma are both common comorbidities among older patients. Combining glaucoma surgery with minimal invasive phacoemulsification (phaco) is a considerable option to treat both conditions at the same time, although the combination with filtration surgery can produce a strong inflammatory response. Combined non-penetrating procedures like canaloplasty have shown to reduce intraocular pressure (IOP) comparable to trabeculectomy without the risk of serious bleb-related complications. The purpose of this retrospective study was to compare the outcomes of phacotrabeculectomy and phacocanaloplasty. Methods Thirty-nine eyes with concomitant cataract and glaucoma who underwent phacotrabeculectomy (n = 20; 51.3\%) or phacocanaloplasty (n = 19; 48.7\%) were included into this trial on reduction of IOP, use of medication, success rate, incidence of complications and postsurgical interventions. Complete success was defined as IOP reduction by 30\% or more and to 21 mmHg or less (definition 1a) or IOP to less than 18 mmHg (definition 2a) without glaucoma medication. Results Over a 12-month follow-up, baseline IOP significantly decreased from 30.0 ± 5.3 mmHg with a mean of 2.5 ± 1.2 glaucoma medications to 11.7 ± 3.5 mmHg with a mean of 0.2 ± 0.4 medications in eyes with phacotrabeculectomy (P < .0001). Eyes with phacocanaloplasty had a preoperative IOP of 28.3 ± 4.1 mmHg and were on 2.8 ± 1.1 IOP-lowering drugs. At 12 months, IOP significantly decreased to 12.6 ± 2.1 mmHg and less glaucoma medications were necessary (mean 1.0 ± 1.5 topical medications; P < .05). 15 patients (78.9\%) with phacotrabeculectomy and 9 patients (60.0\%) in the phacocanaloplasty group showed complete success according to definition 1 and 2 after 1 year (P = .276). Postsurgical complications were seen in 7 patients (36.8\%) of the phacocanaloplasty group which included intraoperative macroperforation of the trabeculo-Descemet membrane (5.3\%), hyphema (21.1\%) and bleb formation (10.5\%). Although more complications were observed in the phacotrabeculectomy group, no statistically significant difference was found. Conclusions Phacocanaloplasty offers a new alternative to phacotrabeculectomy for treatment of concomitant glaucoma and cataract, although phacotrabeculectomy yielded in better results in terms of IOP maintained without glaucoma medications.}, subject = {Augenkrankheit}, language = {en} } @article{MatlachDhillonHainetal.2015, author = {Matlach, Juliane and Dhillon, Christine and Hain, Johannes and Schlunck, G{\"u}nther and Grehn, Franz and Klink, Thomas}, title = {Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trial}, series = {Acta Ophthalmologica}, volume = {93}, journal = {Acta Ophthalmologica}, doi = {10.1111/aos.12722}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-149263}, pages = {753-761}, year = {2015}, abstract = {Purpose: To compare the outcomes of canaloplasty and trabeculectomy in open-angle glaucoma. Methods: This prospective, randomized clinical trial included 62 patients who randomly received trabeculectomy (n = 32) or canaloplasty (n = 30) and were followed up prospectively for 2 years. Primary endpoint was complete (without medication) and qualified success (with or without medication) defined as an intraocular pressure (IOP) of ≤18 mmHg (definition 1) or IOP ≤21 mmHg and ≥20\% IOP reduction (definition 2), IOP ≥5 mmHg, no vision loss and no further glaucoma surgery. Secondary endpoints were the absolute IOP reduction, visual acuity, medication, complications and second surgeries. Results: Surgical treatment significantly reduced IOP in both groups (p < 0.001). Complete success was achieved in 74.2\% and 39.1\% (definition 1, p = 0.01), and 67.7\% and 39.1\% (definition 2, p = 0.04) after 2 years in the trabeculectomy and canaloplasty group, respectively. Mean absolute IOP reduction was 10.8 ± 6.9 mmHg in the trabeculectomy and 9.3 ± 5.7 mmHg in the canaloplasty group after 2 years (p = 0.47). Mean IOP was 11.5 ± 3.4 mmHg in the trabeculectomy and 14.4 ± 4.2 mmHg in the canaloplasty group after 2 years. Following trabeculectomy, complications were more frequent including hypotony (37.5\%), choroidal detachment (12.5\%) and elevated IOP (25.0\%). Conclusions: Trabeculectomy is associated with a stronger IOP reduction and less need for medication at the cost of a higher rate of complications. If target pressure is attainable by moderate IOP reduction, canaloplasty may be considered for its relative ease of postoperative care and lack of complications.}, language = {en} } @article{KlinkSauerKoerberetal.2015, author = {Klink, Thomas and Sauer, Johannes and K{\"o}rber, Norbert J and Grehn, Franz and Much, Martin M and Thederan, Luisa and Matlach, Juliane and Salgado, Josefina Parente}, title = {Quality of life following glaucoma surgery: canaloplasty versus trabeculectomy}, series = {Clinical Ophthalmology}, volume = {9}, journal = {Clinical Ophthalmology}, doi = {10.2147/OPTH.S72357}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-149520}, pages = {7-16}, year = {2015}, abstract = {Purpose: To evaluate quality of life (QoL) with a new questionnaire after canaloplasty (CP) and trabeculectomy (TE). Patients and methods: We assessed outcomes of surgery, rate of revision surgeries, patients' mood, and influence of postoperative care on QoL, surgery interference with daily activities, and postsurgical complaints. Patients completed the QoL questionnaire 24 months after surgery. Results: Patients who underwent CP (n=175) were compared to TE patients (n=152). In the CP group, 57\% of patients expressed high satisfaction, while 41\% of patients in the TE group said they were highly satisfied. The satisfaction difference was statistically significant (P=0.034). Significantly fewer second surgeries were needed after CP (8\% CP versus 35\% TE, P<0.001). Patients were more positive in the CP group (54\% CP versus 37\% TE, P<0.009). Stress related to postoperative care was lower in the CP group compared to the TE group (14\% versus 46\%). Difficulties with activities of daily living, such as reading, were much lower or even nonexistent after CP, and complaints like eye burning or stinging were significantly lower in the CP group. Conclusions: Compared with TE, CP is associated with less QoL impairment and higher patient satisfaction after surgery. However, long-term data on intraocular pressure reduction after surgery are needed to confirm long-term patient satisfaction with this surgery.}, language = {en} } @article{KlinkSauerKoerberetal.2014, author = {Klink, Thomas and Sauer, Johannes and K{\"o}rber, Norbert J. and Grehn, Franz and Much, Martin M. and Thederan, Luisa and Matlach, Juliane and Salgado, Josefina Parente}, title = {Quality of life following glaucoma surgery: canaloplasty versus trabeculectomy}, doi = {10.2147/OPTH.S72357}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-113596}, year = {2014}, abstract = {Purpose: To evaluate quality of life (QoL) with a new questionnaire after canaloplasty (CP) and trabeculectomy (TE). Patients and methods: We assessed outcomes of surgery, rate of revision surgeries, patients' mood, and influence of postoperative care on QoL, surgery interference with daily activities, and postsurgical complaints. Patients completed the QoL questionnaire 24 months after surgery. Results: Patients who underwent CP (n=175) were compared to TE patients (n=152). In the CP group, 57\% of patients expressed high satisfaction, while 41\% of patients in the TE group said they were highly satisfied. The satisfaction difference was statistically significant (P=0.034). Significantly fewer second surgeries were needed after CP (8\% CP versus 35\% TE, P<0.001). Patients were more positive in the CP group (54\% CP versus 37\% TE, P<0.009). Stress related to postoperative care was lower in the CP group compared to the TE group (14\% versus 46\%). Difficulties with activities of daily living, such as reading, were much lower or even nonexistent after CP, and complaints like eye burning or stinging were significantly lower in the CP group. Conclusions: Compared with TE, CP is associated with less QoL impairment and higher patient satisfaction after surgery. However, long-term data on intraocular pressure reduction after surgery are needed to confirm long-term patient satisfaction with this surgery.}, language = {en} } @article{HanKampikGrehnetal.2013, author = {Han, Hong and Kampik, Daniel and Grehn, Franz and Schlunck, G{\"u}nther}, title = {TGF-beta 2-Induced Invadosomes in Human Trabecular Meshwork Cells}, series = {PLoS ONE}, volume = {8}, journal = {PLoS ONE}, number = {8}, doi = {10.1371/journal.pone.0070595}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-130074}, pages = {e70595}, year = {2013}, abstract = {Primary open-angle glaucoma (POAG) is a leading cause of blindness due to chronic degeneration of retinal ganglion cells and their optic nerve axons. It is associated with disturbed regulation of intraocular pressure, elevated intraocular levels of TGF-β2, aberrant extracellular matrix (ECM) deposition and increased outflow resistance in the trabecular meshwork (TM). The mechanisms underlying these changes are not fully understood. Cell-matrix interactions have a decisive role in TM maintenance and it has been suggested that TGF-β-induced inhibition of matrix metalloproteases may drive aberrant ECM deposition in POAG. Invadopodia and podosomes (invadosomes) are distinct sites of cell-matrix interaction and localized matrix-metalloprotease (MMP) activity. Here, we report on the effects of TGF-β2 on invadosomes in human trabecular meshwork cells. Human TM (HTM) cells were derived from donor tissue and pretreated with vehicle or TGF-β2 (2 ng/ml) for 3d. Invadosomes were studied in ECM degradation assays, protein expression and MMP-2 activity were assessed by western blot and zymography and ECM protein transcription was detected by RT-qPCR. HTM cells spontaneously formed podosomes and invadopodia as detected by colocalization of Grb2 or Nck1 to sites of gelatinolysis. Pretreatment with TGF-β2 enhanced invadosomal proteolysis and zymographic MMP-2 activity as well as MMP-2, TIMP-2 and PAI-1 levels in HTM cell culture supernatants. Rho-kinase inhibition by H1152 blocked the effects of TGF-β2. Concomitant transcription of fibronectin and collagens-1, -4 and -6 was increased by TGF-β2 and fibrillar fibronectin deposits were observed in areas of invadosomal ECM remodelling. In contrast to a current hypothesis, our data indicate that TGF-β2 induces an active ECM remodelling process in TM cells, characterized by concurrent increases in localized ECM digestion and ECM expression, rather than a mere buildup of material due to a lack of degradation. Invadosomal cell adhesion and signaling may thus have a role in POAG pathophysiology.}, language = {en} } @article{GlatzelPatzkoMatlachetal.2021, author = {Glatzel, Caroline Maria and Patzk{\´o}, {\´A}gnes and Matlach, Juliane and Grehn, Franz}, title = {Ergebnisse der filtrierenden Trabekulotomie (FTO) im Vergleich zur konventionellen Trabekulektomie (TE) - eine gematchte Fall-Kontroll-Studie}, series = {Der Ophthalmologe}, volume = {118}, journal = {Der Ophthalmologe}, number = {5}, doi = {10.1007/s00347-021-01365-w}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-266542}, pages = {461-469}, year = {2021}, abstract = {Ziel Ziel dieser Studie war es, die 2‑Jahres-Ergebnisse der filtrierenden Trabekulotomie (FTO) im Vergleich zur konventionellen Trabekulektomie (TE) bei prim{\"a}rem Offenwinkelglaukom, Pseudoexfoliationsglaukom und Pigmentglaukom zu untersuchen. Patienten und Methoden Es wurden 30 konsekutive Patienten nach FTO und 87 Patienten nach TE nach intraokularem Druck (IOD) und Alter im Verh{\"a}ltnis 1:3 gematcht. Prim{\"a}rer Endpunkt war das Erreichen des Zieldrucks nach 2 Jahren. Als vollst{\"a}ndiger Erfolg wurde ein IOD ohne Medikamente von ≤ 18 mm Hg bei gleichzeitiger IOD-Reduktion um ≥ 30 \% definiert, als qualifizierter Erfolg, wenn hierf{\"u}r zus{\"a}tzlich Medikamente erforderlich waren. Sekund{\"a}re Endpunkte waren mittlere Drucksenkung, resultierende Sehsch{\"a}rfe, Komplikationen und nachfolgende Operationen. Die Operationstechnik der filtrierenden Trabekulotomie ist als Video zu diesem Beitrag abrufbar. Ergebnisse Zwei-Jahres-Daten konnten von 27 Patienten aus der FTO-Gruppe und 68 Patienten aus der TE-Gruppe erhoben werden. Die Patienten beider Gruppen wurden vor Beginn der Studie bez{\"u}glich Alter und IOD gematcht, waren aber auch bez{\"u}glich Sehsch{\"a}rfe, Geschlecht und Medikation nicht unterschiedlich. Der Median des pr{\"a}operativen IOD unter Therapie betrug in beiden Gruppen 23,0 mm Hg. Nach den oben genannten Kriterien wurde ein qualifizierter 2‑Jahres-Erfolg bei 70,4 \% der FTO-Gruppe und bei 77,6 \% der TE-Gruppe erzielt (p = 0,60), ein vollst{\"a}ndiger 2‑Jahres-Erfolg bei 33,3 \% der FTO-Gruppe und bei 56,7 \% der TE-Gruppe (p = 0,07). Beide Operationsmethoden senkten den Augeninnendruck nach 24 Monaten signifikant (p < 0,001), und zwar auf 12,8 mm Hg in der FTO-Gruppe und 11,0 mm Hg in der TE-Gruppe. Die Sehsch{\"a}rfe war postoperativ bei beiden Gruppen etwas verringert, unterschied sich jedoch nicht signifikant zwischen beiden Gruppen. Komplikations- und Reoperationsrate waren gering und unterschieden sich nicht zwischen den Gruppen. Schlussfolgerung FTO und TE sind nach 2 Jahren weitgehend gleichwertig bez{\"u}glich Zieldruck, IOD-Senkung, Sehsch{\"a}rfe und Komplikationen.}, language = {de} } @article{FreibergMatlachGrehnetal.2013, author = {Freiberg, Florentina Joyce and Matlach, Juliane and Grehn, Franz and Karl, Sabine and Klink, Thomas}, title = {Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy}, series = {Clinical Ophthalmology}, journal = {Clinical Ophthalmology}, doi = {10.2147/OPTH.S41750}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-96546}, year = {2013}, abstract = {Purpose: Scarring after glaucoma filtering surgery remains the most frequent cause for bleb failure. The aim of this study was to assess if the postoperative injection of bevacizumab reduces the number of postoperative subconjunctival 5-fluorouracil (5-FU) injections. Further, the effect of bevacizumab as an adjunct to 5-FU on the intraocular pressure (IOP) outcome, bleb morphology, postoperative medications, and complications was evaluated. Methods: Glaucoma patients (N = 61) who underwent trabeculectomy with mitomycin C were analyzed retrospectively (follow-up period of 25 ± 19 months). Surgery was performed exclusively by one experienced glaucoma specialist using a standardized technique. Patients in group 1 received subconjunctival applications of 5-FU postoperatively. Patients in group 2 received 5-FU and subconjunctival injection of bevacizumab. Results: Group 1 had 6.4 ± 3.3 (0-15) (mean ± standard deviation and range, respectively) 5-FU injections. Group 2 had 4.0 ± 2.8 (0-12) (mean ± standard deviation and range, respectively) 5-FU injections. The added injection of bevacizumab significantly reduced the mean number of 5-FU injections by 2.4 ± 3.08 (P ≤ 0.005). There was no significantly lower IOP in group 2 when compared to group 1. A significant reduction in vascularization and in cork screw vessels could be found in both groups (P < 0.0001, 7 days to last 5-FU), yet there was no difference between the two groups at the last follow-up. Postoperative complications were significantly higher for both groups when more 5-FU injections were applied. (P = 0.008). No significant difference in best corrected visual acuity (P = 0.852) and visual field testing (P = 0.610) between preoperative to last follow-up could be found between the two groups. Conclusion: The postoperative injection of bevacizumab reduced the number of subconjunctival 5-FU injections significantly by 2.4 injections. A significant difference in postoperative IOP reduction, bleb morphology, and postoperative medication was not detected.}, language = {en} }